SOURCES:
Linda Geng, MD, PhD, assistant professor of drugs, Stanford College; co-director, Publish-Acute COVID-19 Syndrome Heart.
Diana Güthe, founder, COVID strengthen team Survivor Corps.
Michael Peluso, MD, infectious sicknesses physician, assistant professor of drugs, College of California, San Francisco.
Zachary Schwartz, MD, scientific director, Publish-COVID-19 Restoration Health center, Vancouver Normal Medical institution, Canada.
Alexander Truong, MD, pulmonologist, Emory College Faculty of Medication.
Monica Verduzco-Gutierrez, MD, bodily medication and rehabilitation physician; director, post-COVID restoration program and health center, San Antonio, TX.
Nature: “Promotion of non-evidence-based therapeutics inside patient-led Lengthy COVID strengthen teams.”
Fb: @COVID19survivorcorps, Might 27, 2022.
Hormone and Metabolic Analysis: “Publish COVID and Apheresis – The place are we Status?”
The BMJ: “Lengthy covid and apheresis: a miracle treatment offered on a speculation of hope,” “Lengthy covid sufferers commute out of the country for dear and experimental ‘blood washing.'”
FDA: “FDA Warns About Stem Cellular Remedies,” “Nutritional Dietary supplements.”
Stem Cellular Studies: “Moral problems and public conversation within the construction of cell-based remedies for COVID-19: Classes from the pandemic.”
Cellular Stem Cellular: “The American stem mobile promote in 2021: U.S. companies promoting unlicensed and unproven stem mobile interventions.”
Clinical Studies: “Hyperbaric oxygen treatment improves neurocognitive purposes and signs of post-COVID situation: randomized managed trial.
